Skip to main content
Fig. 4 | BMC Psychiatry

Fig. 4

From: Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects

Fig. 4

Reduction in mean (standard error) Sheehan Disability Scale total and domain scores from baseline after 3 months of vortioxetine treatment according to vortioxetine dose at study end (observed cases). p < 0.001 for repeated measures analysis of variance Greenhouse–Geisser F and t test for all paired comparisons between the three visits

Back to article page